Stroke Research

With an unwavering commitment to advancement, the University Hospitals Neurological Institute has carved an indelible path in medical research. It consistently takes a leading role in groundbreaking clinical trials, encompassing a wide spectrum from cutting-edge medical devices to revolutionary biologics. Many of the stroke and neurosurgery clinical trials that we conduct at University Hospitals enroll patients who are in the acute stage of their disease or injury. This means that patients are enrolled while they are in the emergency room, intensive care unit, or operating room. 

At the forefront of innovation, the hospital's contributions to the field are exemplified by landmark trials like PROACT 2 and SELECT2, which have catalyzed transformative changes in medical practice. These pivotal trials not only led the way but also prompted profound shifts in how healthcare professionals approach patient care in the field of stroke.

University Hospitals is also an integral member of the StrokeNet Consortium, a collaborative network of top-tier institutions dedicated to advancing stroke research and treatment and supported by the Neurological Disorders and Stroke (one of the National Institutes of Health). Cleveland has been chosen as a Regional Coordinating Center for StrokeNet, which is comprised of the major healthcare institutions in the regions to conduct NIH stroke research, with University Hospitals serving as the primary contact site for NIH.

Through this national collaborative clinical trials network, the Comprehensive Stroke Center has secured over $2 million in clinical research funding, the majority of it coming from the National Institutes of Health (NIH). This affiliation underscores the hospital's pivotal role in shaping medical progress on a global scale. Currently engaged in over 30 ongoing trials, University Hospitals Cleveland Medical Center has successfully enrolled over 1050 patients in various research studies, demonstrating its dedication to pushing the boundaries of medical knowledge.